USE OF TRANSGENIC AND GENE-TARGETED MICE TO MODEL THE GENETIC-BASIS OF HYPERTENSIVE DISORDERS

Citation
Dc. Merrill et al., USE OF TRANSGENIC AND GENE-TARGETED MICE TO MODEL THE GENETIC-BASIS OF HYPERTENSIVE DISORDERS, Proceedings of the Association of American Physicians, 109(6), 1997, pp. 533-546
Citations number
141
Categorie Soggetti
Medicine, General & Internal
ISSN journal
1081650X
Volume
109
Issue
6
Year of publication
1997
Pages
533 - 546
Database
ISI
SICI code
1081-650X(1997)109:6<533:UOTAGM>2.0.ZU;2-4
Abstract
As both essential hypertension and hypertension associated with pregna ncy (pre-eclampsia) have been determined to have strong genetic compon ents, considerable recent research has focused on identifying genes th at may predispose to the development of these disorders, Recent advanc es in molecular genetics and the work of the Human Genome Project have facilitated the identification of genes that may be linked to these h ypertensive disorders. Although molecular genetic studies performed in humans and animals can be used to link genes or mutations in genes to hypertension (once identified), studies are needed to assess their bi ochemical and physiologic importance. In this review, we discuss the e ver-increasing importance and use of transgenic and gene-targeted mice in modeling the genetic basis of hypertensive disorders.